We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Imaging Method Enables Early Detection of Fungal Infections Caused by Aspergillus Fumigatus

By MedImaging International staff writers
Posted on 16 Aug 2024
Print article
Image: Researchers have developed and tested a new imaging method that will allow specific detection of Aspergillus fumigatus fungal infections (Photo courtesy of Shutterstock)
Image: Researchers have developed and tested a new imaging method that will allow specific detection of Aspergillus fumigatus fungal infections (Photo courtesy of Shutterstock)

Delays in diagnosing fungal infections caused by Aspergillus fumigatus and other fungi can be critical for immunocompromised patients, potentially leading to severe illnesses or even death. To address this, researchers have developed a novel imaging method that allows for the specific detection of Aspergillus fumigatus infections promptly, without the need for invasive procedures.

Many fungi, including Aspergillus, have adapted to environmental conditions, allowing them to utilize alternate energy sources apart from glucose, such as breaking down complex sugars like cellobiose into simple glucose molecules. Unlike most other microbes and human cells, Aspergillus has this unique ability. Researchers from the National Institutes of Health’s (NIH) Clinical Center and the National Heart, Lung, and Blood Institute (NHLBI, Bethesda, MD, USA) have created a radioactive form of cellobiose. This substance, when introduced into the bloodstream, can be visualized in the body using positron emission tomography (PET) imaging.

In this study published in Science Translational Medicine, the team injected mice with fungal infections with radioactive cellobiose ([18F]-Fluorocellobiose, [18F]-FCB) and then performed scans using a PET scanner designed for small animals. The results showed that the mice with fungal infections accumulated radioactivity, whereas those with bacterial infections or non-infectious inflammation did not. Additionally, the researchers found that the radioactive tracer [18F]-FCB can be used to determine if the mice with fungal infections respond to treatment by comparing PET images taken before and after treatment initiation.

Related Links:
NHLBI

Diagnostic Ultrasound System
MS1700C
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Portable Color Doppler Ultrasound Scanner
DCU10
3T MRI Scanner
MAGNETOM Cima.X

Print article

Channels

MRI

view channel
Image: Comparison showing 3T and 7T scans for the same participant (Photo courtesy of P Simon Jones/University of Cambridge)

Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients

Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more

Ultrasound

view channel
Image: Oloid-shaped magnetic endoscope (Photo courtesy of STORM Lab/University of Leeds)

Tiny Magnetic Robot Takes 3D Scans from Deep Within Body

Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.